Search research articles
Contact Us
Filters
Showing results (361-370 of 387) with videos related to
Page
of 39
Sort By:
Cancer
|
October 1, 1995
Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas
H Taubert, P Würl, A Meye, et al.
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
|
January 1, 1991
Toxicological investigations of waste products from the plasma etching process in the semiconductor industry
S Bauer, I Wolff, N Werner, et al.
Scandinavian Journal of Gastroenterology
|
December 17, 1997
Detection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevance
P Würl, F Weigmann, A Meye, et al.
Cancer Letters
|
July 8, 1999
Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomas
P Würl, A Meye, C Lautenschläger, et al.
International Journal of Cancer
|
April 6, 2001
Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53
M Bache, S Pigorsch, J Dunst, et al.
Geburtshilfe Und Frauenheilkunde
|
September 2, 2016
Maternal Serum Lipid, Estradiol, and Progesterone Levels in Pregnancy, and the Impact of Placental and Hepatic Pathologies
U Pecks, W Rath, N Kleine-Eggebrecht, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 29, 2001
Tumor hypoxia, p53, and prognosis in cervical cancers
G Haensgen, U Krause, A Becker, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 24, 2001
[Association between elevated serum VEGF and polarographically measured tumor hypoxia in head and neck carcinomas]
A Becker, P Stadler, U Krause, et al.
Cancer Genetics and Cytogenetics
|
January 15, 1998
Cytogenetic characterization of ten malignant fibrous histiocytomas
H Schmidt, S Körber, R Hinze, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|
March 30, 1999
[p53 overexpression as independent prognostic marker in soft tissue sarcomas is antibody dependent]
P Würl, H Taubert, A Meye, et al.
Page
of 39
Search research articles
Search
Showing results (361-370 of 387) with videos related to
Sort By:
Page
of 39
Cancer
|
October 1, 1995
Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas
H Taubert, P Würl, A Meye, et al.
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement
|
January 1, 1991
Toxicological investigations of waste products from the plasma etching process in the semiconductor industry
S Bauer, I Wolff, N Werner, et al.
Scandinavian Journal of Gastroenterology
|
December 17, 1997
Detection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevance
P Würl, F Weigmann, A Meye, et al.
Cancer Letters
|
July 8, 1999
Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomas
P Würl, A Meye, C Lautenschläger, et al.
International Journal of Cancer
|
April 6, 2001
Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53
M Bache, S Pigorsch, J Dunst, et al.
Geburtshilfe Und Frauenheilkunde
|
September 2, 2016
Maternal Serum Lipid, Estradiol, and Progesterone Levels in Pregnancy, and the Impact of Placental and Hepatic Pathologies
U Pecks, W Rath, N Kleine-Eggebrecht, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 29, 2001
Tumor hypoxia, p53, and prognosis in cervical cancers
G Haensgen, U Krause, A Becker, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
May 24, 2001
[Association between elevated serum VEGF and polarographically measured tumor hypoxia in head and neck carcinomas]
A Becker, P Stadler, U Krause, et al.
Cancer Genetics and Cytogenetics
|
January 15, 1998
Cytogenetic characterization of ten malignant fibrous histiocytomas
H Schmidt, S Körber, R Hinze, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|
March 30, 1999
[p53 overexpression as independent prognostic marker in soft tissue sarcomas is antibody dependent]
P Würl, H Taubert, A Meye, et al.
Page
of 39